Dallán Ryan

Importance of Point-in-Time for Alternative Data

Importance of Point-in-Time for Alternative Data

This white paper explores the significance and application of Point-in-Time (PIT) data, which captures information at a specific moment, providing a snapshot of data distinct from time-series data. PIT data, critical for eliminating biases such as look-ahead and look-behind biases, is crucial for systematic firms to avoid “survivorship bias” by reflecting the true historical landscape without alterations caused by company changes or corrections.

Importance of Point-in-Time for Alternative Data

Data Regulators in China, the UK, and Europe Are Making Moves – What Alternative Data Users Should Know

Regulatory activities in the UK, Europe, and China were recently discussed as part of Eagle Alpha’s monthly alternative data-focused workshops for asset managers in collaboration with legal partners Schulte Roth & Zabel. Anna-Maleva Otto, a partner at Schulte Roth & Zabel, and Samuel Yang, a partner at AnJie Law discussed the developments that have shaped the data landscape in 2023 and what can be expected in 2024.

Alternative Data for Technology

Alternative Data for Technology

This white paper delves into the profound shifts within the tech sector brought on by the COVID-19 pandemic, spotlighting the accelerated adoption of remote work practices and the heightened demand for various technological products and services. In detailing the tech industry’s journey towards recovery in 2023, the paper underscores the sector’s resilience and its capacity to adapt, fueled by a resurgent interest in AI alongside progress in other technological domains. Data-driven insights emerge as crucial tools for comprehending the fluid market landscape.

Eagle Alpha Data Monetization Guide

Eagle Alpha Data Monetization Guide

Eagle Alpha’s role is critical in guiding corporations, consultants, or technology partners through the multifaceted journey of data monetization. This process involves an evaluation of the data’s value proposition, guidance on standardized legal and compliance frameworks, productization decisions and the strategic positioning of data products for the financial market.

Alternative Data for Healthcare

Alternative Data for Healthcare

This white paper explores the impact of alternative data sources on the healthcare industry, emphasizing their role in enhancing investment decisions in healthcare startups, therapies, and market trends. It delves into patient-generated data, wearables, mobile health apps, social media discussions, and electronic health records (EHRs) as key non-traditional data sources. The report segments healthcare data into four primary categories: R&D and clinical trials, claims data, medical devices data, and other relevant datasets, underscoring the transformative role of AI in healthcare processes. The paper includes sections on investment trends in pharma and biomed, data availability and its applications, the evolution of the pharma industry through AI, real-world case studies demonstrating successful data utilization, and compliance considerations for investors. This summary offers a glimpse into the comprehensive insights provided in the full report by Eagle Alpha, which further includes additional case studies and details on alternative data providers not covered here. For more detailed information and access to a broad catalog of data products, the report encourages contacting Eagle Alpha directly.